CellSource raised its revenue and operating profit forecasts for FY October 2026 after contract processing services exceeded expectations. The increased contribution from contract processing services was cited as a factor behind the sharp rebound.
CellSource’s share price rebounded sharply after its contract processing services were reported to have contributed more than expected. Although the article does not provide specific figures, the company raised its earnings forecasts for FY October 2026.